SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Cardiovascular Pharmacology and Therapeutics
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Sakai, F.
Right arrow Articles by Hiraoka, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Sakai, F.
Right arrow Articles by Hiraoka, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Electrophysiologic Effects of Beta-blocking Agent, Tilisolol; on Isolated Guinea Pig Ventricular Myocytes

Fumio Sakai

Department of Anesthesiology and Critical Care Medieine, School of Medicine, Tokyo Medical and Dental University, Tokyo, Japan

Seiko Kawano

Department of Cardiovascular Diseases, Medical Research Institute

Masayasu Hiraoka

Department of Cardiovascular Diseases, Medical Research Institute

Background: Electrophysiologic effects of a beta-blocking agent, tilisolol, were studied with isolated guinea pig ventricular myocytes using the whole cell patch clamp technique.

Methods and Results:. Tilisolol at 10 µM or higher concentrations prolonged action poten tial duration (APD) at 90% repolarization (APD90) and at 100 µM or higher concentrations shortened APD at 20% repolarization (APD20) without changes in resting membrane poten tial. At 10 µM concentration tilisolol prolonged APD90 from 236.6 ± 55.3 ms in the control to 253.4 ± 52.4 ms (n = 16; P < .0 L), while APD20 was unaffected. At 100 µM tilisolol, APD20 was shortened from 143.6 ± 15.7 ms in the control to 133.7 ± 22.6 ms (n = 8; P < .05). Under voltage clamp, tilisolol decreased the delayed rectifier K+ current (IK), while the drug little affected the inward rectified K+ current (IKI). Applications of 10 µM and 100 µM tilisolol reduced the maximal conductance of IK by 35.7 ± 3.5% and 47.4 ± 3.5% of the control, respectively, without changes in voltage dependence (n = 10). Tilisolol at 100 µM decreased the L-type Ca2+, current (I Ca.L) by 22.0 ± 9.8% (n = 6) of the control, and the inactivation curve was shifted to a hyperpolarizing direction.

Conclusions: Tilisolol has a direct membrane action to depress IK and ICa.L, in addition to its beta-receptor blocking action.

Key Words: tilisolol • delayed rectified K+ current (IK) • L-type2+ current (ICa.L) • guinea pig ven tricular myocytes.

Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 1, No. 1, 41-48 (1996)
DOI: 10.1177/107424849600100107


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement